Avantor, Inc. Employee Benefits and Share-based Compensation
Avantor, Inc. (AVTR) reported Employee Benefits and Share-based Compensation of -$100.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-04-29
- Avantor, Inc. employee benefits and share-based compensation for the quarter ending 2026-03-31 was -$100.00K, a 105.88% decline year-over-year.
- Avantor, Inc. employee benefits and share-based compensation for the quarter ending 2025-12-31 was $2.30M.
- Avantor, Inc. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $7.50M, a 1775.00% increase year-over-year.
- Avantor, Inc. employee benefits and share-based compensation for the quarter ending 2025-06-30 was $2.50M, a 316.67% increase year-over-year.
- Avantor, Inc. employee benefits and share-based compensation for fiscal 2025 was $14.00M, a 1455.56% increase from fiscal 2024.
- Avantor, Inc. employee benefits and share-based compensation for fiscal 2024 was $900.00K, a 200.00% increase from fiscal 2023.
- Avantor, Inc. employee benefits and share-based compensation for fiscal 2023 was $300.00K.
- Avantor, Inc. employee benefits and share-based compensation for fiscal 2022 was -$3.30M, a 210.00% decline from fiscal 2021.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$100.00K 10-Q · filed 2026-04-29 | $2.20M derived: sum of 2 quarters · filed 2026-04-29 | $9.70M derived: sum of 3 quarters · filed 2026-04-29 | $12.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $9.80M derived: sum of 2 quarters · filed 2026-02-11 | $12.30M derived: sum of 3 quarters · filed 2026-02-11 | $14.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $7.50M 10-Q · filed 2025-10-29 | $10.00M derived: sum of 2 quarters · filed 2025-10-29 | $11.70M 10-Q · filed 2025-10-29 | $11.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $2.50M 10-Q · filed 2025-08-01 | $4.20M 10-Q · filed 2025-08-01 | $3.70M derived: sum of 3 quarters · filed 2026-04-29 | $4.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $1.70M 10-Q · filed 2026-04-29 | $1.20M derived: sum of 2 quarters · filed 2026-04-29 | $1.60M derived: sum of 3 quarters · filed 2026-04-29 | $2.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$100.00K derived: sum of 2 quarters · filed 2026-02-11 | $500.00K derived: sum of 3 quarters · filed 2026-02-11 | $900.00K 10-K · filed 2026-02-11 |
| 2024-09-30 | $400.00K 10-Q · filed 2025-10-29 | $1.00M derived: sum of 2 quarters · filed 2025-10-29 | $1.40M 10-Q · filed 2025-10-29 | $1.50M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $600.00K 10-Q · filed 2025-08-01 | $900.00K 10-Q · filed 2025-08-01 | $1.10M derived: sum of 3 quarters · filed 2026-02-11 | $1.20M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $300.00K 10-Q · filed 2025-04-25 | $500.00K derived: sum of 2 quarters · filed 2026-02-11 | $600.00K derived: sum of 3 quarters · filed 2026-02-11 | $500.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $300.00K derived: sum of 2 quarters · filed 2026-02-11 | $200.00K derived: sum of 3 quarters · filed 2026-02-11 | $300.00K 10-K · filed 2026-02-11 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $100.00K 10-Q · filed 2023-10-27 | $100.00K derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | -$100.00K 10-Q · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-07 | -$1.60M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-04-26 | $100.00K derived: sum of 2 quarters · filed 2025-02-07 | -$1.50M derived: sum of 3 quarters · filed 2025-02-07 | -$1.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | -$1.60M derived: sum of 2 quarters · filed 2025-02-07 | -$2.00M derived: sum of 3 quarters · filed 2025-02-07 | -$3.30M 10-K · filed 2025-02-07 |
| 2022-09-30 | -$1.60M 10-Q · filed 2023-10-27 | -$2.00M derived: sum of 2 quarters · filed 2023-10-27 | -$3.30M 10-Q · filed 2023-10-27 | -$3.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$400.00K 10-Q · filed 2023-07-28 | -$1.70M 10-Q · filed 2023-07-28 | -$1.60M derived: sum of 3 quarters · filed 2024-02-14 | $0.00 derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$1.30M 10-Q · filed 2023-04-28 | -$1.20M derived: sum of 2 quarters · filed 2024-02-14 | $400.00K derived: sum of 3 quarters · filed 2024-02-14 | $1.10M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.70M derived: sum of 2 quarters · filed 2024-02-14 | $2.40M derived: sum of 3 quarters · filed 2024-02-14 | $3.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $1.60M 10-Q · filed 2022-10-28 | $2.30M derived: sum of 2 quarters · filed 2022-10-28 | $2.90M 10-Q · filed 2022-10-28 | $3.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $700.00K 10-Q · filed 2022-07-29 | $1.30M 10-Q · filed 2022-07-29 | $2.00M derived: sum of 3 quarters · filed 2023-02-14 | $2.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $600.00K 10-Q · filed 2022-04-29 | $1.30M derived: sum of 2 quarters · filed 2023-02-14 | $1.90M derived: sum of 3 quarters · filed 2023-02-14 | $3.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $1.30M derived: sum of 2 quarters · filed 2023-02-14 | $2.40M derived: sum of 3 quarters · filed 2023-02-14 | $1.30M 10-K · filed 2023-02-14 |
| 2020-09-30 | $600.00K 10-Q · filed 2021-10-29 | $1.70M derived: sum of 2 quarters · filed 2021-10-29 | $600.00K 10-Q · filed 2021-10-29 | $3.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $1.10M 10-Q · filed 2021-07-30 | $0.00 10-Q · filed 2021-07-30 | $3.30M derived: sum of 3 quarters · filed 2022-02-11 | -$5.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$1.10M 10-Q · filed 2021-04-28 | $2.20M derived: sum of 2 quarters · filed 2022-02-11 | -$7.00M derived: sum of 3 quarters · filed 2022-02-11 | $35.70M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$5.90M derived: sum of 2 quarters · filed 2022-02-11 | $36.80M derived: sum of 3 quarters · filed 2022-02-11 | $36.80M 10-K · filed 2022-02-11 |
| 2019-09-30 | -$9.20M 10-Q · filed 2020-10-27 | $33.50M derived: sum of 2 quarters · filed 2020-10-27 | $33.50M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $42.70M 10-Q · filed 2020-07-29 | $42.70M 10-Q · filed 2020-07-29 | ||
| 2018-12-31 | -$700.00K 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |